ponatinib cancer drug molecule. tyrosine kinase inhibitor used in treatment of chronic myeloid leukemia cml and acute.

acute all atomic atoms bcrabl carbon chemical chemistry chromosome chronic composition disease drug fluorine generic hydrogen inhibitor kinase leukemia lymphoblastic medicinal medicine model molecular molecule mutation myeloid nitrogen oxygen pharma pharmaceutical pharmacology pharmacy philadelphia ponatinib ponatinibe product therapy treatment tyrosine